Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis

Abstract

Rheumatoid arthritis is an auto-immune disease of the synovial joints, hallmarked by chronic inflammation and subsequent progressive tissue destruction. TYRO3, AXL and MER (gene name Mertk) (TAM) receptors are part of a negative feedback signaling system in the immune reaction and mediate efferocytosis thereby tempering the inflammatory process. We have shown that Axl-/- and Mertk-/- mice develop more severe arthritis whereas activating these receptors by overexpressing their ligands Pros1 and Gas6 ameliorates arthritis. Mice genetically ablated for the three genes of the TAM receptor family Tyro3/Axl/Mertk (TAM triple knock-out or TKO) have been described to spontaneously develop macroscopic signs of arthritis. In this study we aimed to analyze arthritis development in TAM TKO mice histologically to determine the extent and sequence of pathological changes in the joint. Ankle joints of three different age groups, adolescence (14 weeks), mature adult (34 weeks) and middle-age (52 weeks), of TAM TKO or wild-type mice were examined macroscopically, histologically and immunohistochemically. Surprisingly, until the age of 52 weeks, none of the mice examined developed spontaneous macroscopic signs of arthritis. There was no synovial inflammation nor any signs of damage to the cartilage or bone. However, bone marrow edema was observed in TAM TKO mice in the two latter age groups. The infiltrate in the bone marrow was characterized by both myeloid cells and lymphocytes. This study showed that TAM TKO mice developed a pre-stage (pre-clinical phase) of arthritis marked by bone marrow edema.

About the Authors:

Claire E. J. Waterborg

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Experimental Rheumatology, Department of Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

ORCID logo http://orcid.org/0000-0001-7709-2167

Marije I. Koenders

Roles Writing – review & editing

Affiliation: Experimental Rheumatology, Department of Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

Peter L. E. M. van Lent

Roles Writing – review & editing

Affiliation: Experimental Rheumatology, Department of Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

Peter M. van der Kraan

Roles Supervision, Writing – review & editing

Affiliation: Experimental Rheumatology, Department of Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

Fons A. J. van de Loo

Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing

* E-mail: [email protected]

Affiliation: Experimental Rheumatology, Department of Rheumatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

ORCID logo http://orcid.org/0000-0002-5851-099X

Introduction

Rheumatoid arthritis (RA) is an auto-immune disease marked by chronic and unrestrained inflammation, often in multiple synovial joints in the same patient. In the arthritic joint, the synovium is infiltrated by both innate and adaptive immune cells which, together with the proliferation of the tissue-resident fibroblasts, leads to pannus tissue formation at the articular cartilage and bone interface. Overall, this eventually leads to damage and loss of the articular cartilage matrix and bone tissue [1, 2].

One family of receptors that has been linked to RA and experimental models of RA are the TAM receptors [3–10]. The TAM receptors–TYRO3, AXL and MER (gene name Mertk)–are a family of tyrosine kinases essential for immune homeostasis by negatively regulating the innate immune response. Together with their ligands Growth Arrest Specific 6 (GAS6) and Protein S (PROS1), they also mediate the resolution of inflammation by facilitating efferocytosis [11]. We have found that both AXL and MER play a suppressive role by alleviating joint inflammation and others have found that TYRO3 plays an enhancing role in bone degradation and synovial hyperplasia in experimental arthritis [5, 7, 10] (manuscript under review).

More than a decade ago, it was reported that mice lacking all three TAM receptors (triple knock-out or TKO) develop a lymphoproliferative disorder accompanied by broad-spectrum autoimmunity including splenomegaly [12]. In this paper, they showed TAM TKO mice spontaneously developed clinical characteristics of RA including swollen footpads in a 6-month-old mouse. Furthermore, deficiency of all three receptors led to enhanced proliferation of both B cells and T cells. Moreover, auto-antibodies were detectable in serum of these mice.

In this study, we aimed to analyze arthritis development in TAM TKO mice histologically to determine the extent and sequence of pathological changes in the disease-prone ankle joints. Surprisingly, until the age of 52 weeks, none of the TAM TKO mice examined developed any macroscopic signs of arthritis. Histologically, neither tissue destruction nor synovial inflammation was observed. However, bone marrow edema (BME), which was characterized by an infiltrate of myeloid cells and lymphocytes, was present at the age of 34 weeks which had persisted to the age of 52 weeks.

Materials and methods

Mice

Tyro3/Axl/Mertk-deficient mice were generated as described previously [13]. Mice were bred and housed in the Salk Institute Animal Facility under a 12 hour light/dark cycle in individually-ventilated cages, with freely available food and water. Mice were on a mixed C57BL/6 × 129/Sv background. Both male and female mice were used, and wild-type (WT) and Tyro3/Axl/Mertk-deficient mice were sex-matched. At the ages of 14 weeks (n = 6), 34 weeks (n = 6) and 52 weeks (n = 12) (adolescent, mature adult and middle-age, respectively), mice were sacrificed by an overdose of isoflurane. As the mice were not visibly affected and suffering by the genotype, no analgesics were used to alleviate suffering. All procedures were approved by and conducted according to guidelines established by the Salk Institutional Animal Care and Use Committee (IACUC).

Histology

Whole ankle joints were dissected, fixed in 4% phosphate-buffered formalin, followed by decalcification with 5% formic acid for 7 days. Tissues were dehydrated with an automated tissue processing apparatus (Leica ASP 300, Leica Biosystems) and embedded in paraffin. Semi-serial tissue sections (7 μm) were stained with hematoxylin and eosin (H&E) (both Merck), safranin O and fast green (both Brunschwig Chemie) or were used for immunohistochemical staining.

Quantification of synovial cellularity and BME

Histological slides of ankle joints stained with H&E were blinded and randomized. For randomization, each joint was given a random number. Pictures of the indicated region of the ankle joint were taken with the Leica DMR microscope (Leica Microsystems) at 50x magnification. To measure the synovial cellularity, the surface area of the synovium was selected as the region of interest. The surface area staining positive for H&E was measured and corrected for the total area that was measured. To measure BME, the surface area of the bone marrow cavity was selected as the region of interest. The surface area staining positive for H&E was measured and corrected for the total area (bone marrow cavity) that was measured. Two to three tissue sections were examined per ankle joint per region (tibia, os talus or os naviculare), the average of two to three sections per region was calculated and is depicted. For all measurements, Leica Application Suite software (Leica Microsystems) was used. WT controls were set at 1 in Figs 1 and 3. WT controls of different ages were compared in S1 Fig and area over total area, calculated as percentage, is depicted

Quantification of articular cartilage depletion

Histological slides of ankle joints stained with safranin O and fast green were blinded and randomized. For randomization, each joint was given a random number. Pictures of the indicated region of the ankle joint were taken with the Leica DMR microscope (Leica Microsystems) at 100x magnification. Two to three tissue sections were examined per ankle joint per region, the average per joint was calculated and is depicted. To determine cartilage depletion, mean blue was measured using Leica Application Suite software (Leica Microsystems). The surface area of the cartilage was selected and the amount of blue light passing through the region of interest was measured by the software. WT controls were set at 1.

Immunohistochemistry

Protein expression was evaluated on 7 μm tissue sections of ankle joints. Sections were deparaffinized and rehydrated. Endogenous peroxidase was blocked by 3% (v/v) hydrogen peroxide in methanol for 20 minutes at room temperature (RT). Sections were washed in between incubation steps with phosphate-buffered saline (PBS) 3 times for 5 minutes. For all sections, a biotin-streptavidin horseradish peroxidase detection system was used according to manufacturer’s protocol (Vector Laboratories; PK6101). Bound complexes were visualized with diaminobenzidine (DAB) (Merck) for 10 minutes at RT. Sections were counterstained with hematoxylin for 30 seconds. Sections were dehydrated and enclosed with Permount.

F4/80.

For F4/80 detection, antigen-retrieval was performed in citrate buffer (pH 6.0) heated to 37ºC for 2 hours and subsequent trypsin treatment (Sigma; T-9201; 0.075% in PBS) at 37°C for 7 minutes. Sections were blocked by 10% (v/v) rabbit serum in PBS for 20 minutes at RT. Tissue sections were incubated with rat anti-mouse F4/80 (eBioscience; 14-4801-81; monoclonal (BM8); 1 μg/mL) or rat IgG2a (BD Pharmingen; 553927; 1 μg/mL) overnight at 4°C. Subsequently, sections were incubated with biotinylated rabbit anti-rat IgG (Vector Laboratories; BA-4001; 1:200) for 30 minutes at RT. Antibodies were diluted in 2% (v/v) rabbit serum in PBS.

CD3.

For CD3 detection, antigen retrieval was performed in citrate buffer (pH 6.0) heated to 60ºC for 10 minutes. Sections were blocked by 5% (w/v) skimmed milk (ELK) 3% (v/v) fetal calf serum (FCS) 2% (w/v) bovine serum albumin (BSA) in PBS for 1 hour at RT. Tissue sections were incubated with rabbit anti-mouse CD3 (DAKO; A0452; polyclonal; 3 μg/mL) or rabbit IgG control (DAKO; X0936; 3 μg/mL) overnight at 4°C. Subsequently, sections were incubated with biotinylated goat anti-rabbit IgG (PK6101; 1:400) for 30 minutes at RT. Antibodies were diluted in 5% ELK 3% FCS 2% BSA in PBS.

CD19.

For CD19 detection, antigen retrieval was performed in citrate buffer heated (pH 6.0) to 60ºC for 10 minutes. Sections were blocked by 5% ELK 3% FCS 2% BSA in PBS for 1 hour at RT. Tissue sections were incubated with rabbit anti-mouse CD19 (Abcam; ab203615; polyclonal; 0.4 μg/mL) or rabbit IgG control (DAKO; X0936; 0.4 μg/mL) overnight at 4°C. Subsequently, sections were incubated with biotinylated goat anti-rabbit IgG (PK6101; 1:400) for 30 minutes at RT. Antibodies were diluted in 5% ELK 3% FCS 2% BSA in PBS.

Statistical analysis

Data were analyzed with GraphPad Prism software (version 5.03). Data are shown as dot-plots with mean. Analysis of significance was performed using a two-tailed Mann Whitney test. p-Values lower than 0.05 were considered to be significantly different.

Results

Synovial cellularity and connective tissue integrity is unaltered in the ankle joints of mice genetically ablated for Tyro3/Axl/Mertk

We examined the ankle joints of mice deficient for Tyro3/Axl/Mertk at three different ages, namely adolescence (14 weeks), mature adult (34 weeks) and middle-age (52 weeks). Surprisingly, we found that TAM TKO mice up to 1 year of age did not develop any macroscopic arthritis-like symptoms, such as swollen toes or footpads, spontaneously. The ankle joint is the privileged site of disease in spontaneous arthritis models [14], but histological examination showed that the ankle joints in the TAM TKO mice appeared to be indistinguishable from their WT controls. The synovial cellularity was comparable between TAM TKO and WT mice at all three ages (Fig 1). Next, we examined the tissue destruction. No bone erosion was observed in any of the mice. In addition, no cartilage erosion was observed nor were there any prominent and significant differences on the upper-layer depletion of cartilage proteoglycan (loss of safranin O staining of the non-calcified upper cartilage layer) (Fig 2).

[Figure omitted. See PDF.]

Fig 1. Effect of genetic deletion of Tyro3/Axl/Mertk on synovial cellularity in ankle joints.

(A) Ankle joints of naive wild-type (WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology. Sections were stained with hematoxylin and eosin. Shown are representative pictures in 50x magnification. Staining is representative for 6 mice (14 and 34 weeks old mice) or 12 mice (52 weeks old mice). (B) Synovial cellularity was quantified in all joints in a random and blinded manner using Leica Application Suite software. Data are presented as dot-plots with mean. Data were statistically analyzed with a Mann Whitney test. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. BM = bone marrow, ON = os naviculare, OT = os talus, S = synovium, T = tibia. Black scale bars represent 100 μm.

https://doi.org/10.1371/journal.pone.0205902.g001

[Figure omitted. See PDF.]

Fig 2. Effect of genetic deletion of Tyro3/Axl/Mertk on cartilage destruction in ankle joints.

(A) Ankle joints of naive wild-type (WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology. Sections were stained with safranin O and fast green. Shown are representative pictures of the tibia–os talus region and os talus–os naviculare region in 50x magnification. Staining is representative for 6 mice (14 and 34 weeks old mice) or 12 mice (52 weeks old mice). (B) Cartilage proteoglycan depletion was quantified in both regions in all joints in a random and blinded manner using Leica Application Suite software. Data are presented as dot-plots with mean. Data were statistically analyzed with a Mann Whitney test. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. ON = os naviculare, OT = os talus, T = tibia. Black scale bars represent 100 μm.

https://doi.org/10.1371/journal.pone.0205902.g002

TAM TKO mice develop BME in the ankle joint region

No tissue destruction nor synovial inflammation was present in any of the joints examined in TAM TKO mice (Figs 1 and 2). Therefore, we focused on BME, a phenomenon which has been described to be present in the preclinical phase of RA [15, 16]. It appeared that TAM TKO mice developed an inflammatory infiltrate in the bone marrow replacing the fat-rich marrow, termed BME. Indeed, BME was enhanced in TAM TKO mice compared to WT in all three regions investigated in mature and middle-age mice (Fig 3). During aging, the fat-rich bone marrow composition in the WT mice was not changed (see S1 Fig). These data show that the TAM TKO mice examined developed early signs of arthritis without signs of joint pathology characteristic for full-blown arthritis.

[Figure omitted. See PDF.]

Fig 3. Effect of genetic deletion of Tyro3/Axl/Mertk on bone marrow edema.

Ankle joints of naive wild-type (WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 14, 34 and 52 weeks old were processed for histology. (A) Sections were stained with hematoxylin and eosin. Shown are representative pictures in 100x magnification of the os naviculare, os talus and tibia of 52 weeks old mice. Staining is representative for 12 mice. (B) Bone marrow edema was quantified in all joints in a random and blinded manner using Leica Application Suite software. Data are presented as dot-plots with mean. Data were statistically analyzed with a Mann Whitney test. * = p<0.05, ** = p<0.01. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. Black scale bars represent 100 μm. See S1 Fig for comparison of bone marrow edema quantification in WT mice among different ages.

https://doi.org/10.1371/journal.pone.0205902.g003

BME in TAM TKO mice is characterized by cells of myeloid and lymphocyte lineage

To further characterize the type of cells of the BME, cells were examined morphologically and cell surface markers were examined by immunohistochemistry. Although to a lesser extent than in WT mice, adipocytes were still present in the bone marrow of TAM TKO mice (Fig 3A, Fig 4). The infiltrate in the bone marrow of TAM TKO mice consisted of a significant amount of F4/80+ macrophages (Fig 4A). Moreover, cells of the lymphoid lineage were also abundantly present. CD20+ B cells, and to a lesser extent, CD3+ T cells were scattered between the F4/80+ cells (Fig 4B and 4C).

[Figure omitted. See PDF.]

Fig 4. Characterization of bone marrow cells in mice lacking Tyro3/Axl/Mertk.

Ankle joints of naive wild-type (WT) and Tyro3/Axl/Mertk triple knock-out (TAM TKO) mice of 52 weeks old were processed for histology. Sections were immunohistochemically stained for the cell surface marker of interest, or IgG negative control, and counterstained with hematoxylin. Shown are representative pictures in 200x magnification of the os naviculare, os talus and tibia. Staining is representative for 12 mice. (A) F4/80, (B) CD3, (C) CD19. Black scale bars represent 100 μm.

https://doi.org/10.1371/journal.pone.0205902.g004

Discussion

In this manuscript, we describe that mice deficient for Tyro3/Axl/Mertk do not develop clinical characteristics of arthritis until the age of 52 weeks. Nonetheless, they do develop an early phenomenon observed in RA, but which is not specific for RA, namely BME. However, in contrast to the publication in 2001 [12], they do not (any longer) develop any aberrant macroscopic signs of arthritis at mature adulthood. Moreover, histologically, joints are not characterized by synovial inflammation and lymphocyte invasion. This is remarkable as the source of the mice was from the same laboratory where they were initially described. Nevertheless, we cannot exclude that TAM TKO mice develop macroscopic signs of arthritis, synovial inflammation or connective tissue destruction at ages over 52 weeks.

In RA, the fat-rich tissue in the bone marrow, also called the yellow marrow, can be replaced by a cell-rich inflammatory environment. This phenomenon, called BME, strongly associates with development of bone erosions and poor functional outcome in patients with RA [17–21]. Very early in the disease process, BME is present and prognostic for the development from undifferentiated arthritis to RA [15, 16, 22]. Moreover, BME is the strongest predictor for bone erosions in RA patients using magnetic resonance imaging (MRI) [17–21]. Histological and immunohistochemical analysis showed that BME observed by MRI is characterized by an infiltrate of inflammatory cells into the bone marrow normally replaced by adipocytes upon ageing. The infiltrate mainly consists of lymphocytes, CD3+, CD4+, or CD8+ T cells and CD20+ B cells, but also CD68+ macrophages have been described [23–28]. One study in TNF-transgenic mice showed that the BME observed in these mice consisted mainly of myeloid cells [29]. We show that the BME observed in TAM TKO mice is also characterized by the presence of both lymphocytes and macrophages, the latter being abundantly present as quantified by the presence of the macrophage marker F4/80. This may confirm the lymphoproliferative disorder in the TAM TKO mice, caused by constitutively active cells of the myeloid lineage, as elegantly demonstrated by adoptive cell transfers [12]. It is unknown whether the lymphocytes in these mice were targeting any joint-specific antigens that could cause joint-specific disease.

It is tempting to speculate that the absence of spontaneous arthritis development we observed compared to the publication of Lu and Lemke [12], is a result of an interaction between genetic and environmental factors. Phenotypic differences in mice with similar genotypes, although from a different breeding generation, have been described before [30]. Moreover, long-term breeding of mouse lines results in marked changes in intestinal microbiota composition and microbiota can account for genotype-specific phenotypes [31]. This is in line with overall better hygiene and housing facilities of mice compared to a decade ago. Numerous studies implicate mucosal surfaces as sites of disease initiation in RA [32]. The simultaneous occurrence of periodontitis, a bacterial-induced inflammation of the gums, and RA suggests that oral pathogens may initiate the production of disease-specific antibodies against citrullinated proteins (ACPA) [33]. This coincides with the fact that periodontitis is characterized by the presence of similar citrullinated auto-antigens in neutrophils, caused by the bacteria Aggregatibacter actinomycetemcomitans, as found in the arthritic joint [34]. Interestingly, the TAM receptor ligand GAS6 has been shown to be an immunological regulator in oral mucosal homeostasis [35].

Currently, it remains to be elucidated what causes BME development in TAM TKO mice. We have shown that MER mediates efferocytosis in the arthritic joint [10]. Moreover, AXL plays a protective role in experimental arthritis, possibly by regulating the post-translational activation of IL-1β (manuscript accepted for publication). However, none of the joints examined in the single knock-out mice for Axl and Mertk showed any signs of BME, nor did the Axl/Mertk double knock-out (own observations). Therefore, it appears that all 3 receptors need to be knocked-out in order to develop this phenotype. As we found BME in mature TAM TKO mice, and this is a phenomenon present in preclinical RA, it is interesting to investigate whether it would be effective to treat these patients with GAS6 in a preclinical stage to stop the progression of BME and subsequent bone erosions. To conclude, TAM TKO mice develop and early stage of RA, namely BME, without spontaneously developing clinical and histopathological signs of arthritis.

Supporting information

[Figure omitted. See PDF.]

S1 Fig. Effect of aging on bone marrow edema.

Ankle joints of naive wild-type mice of 14, 34 and 52 weeks old were processed for histology. Sections were stained with hematoxylin and eosin. Bone marrow edema was quantified in the os naviculare, os talus and tibia in a random and blinded manner using Leica Application Suite software. Data are presented as dot-plots with mean. n = 6 at 14 and 34 weeks old, n = 12 at 52 weeks old. See Fig 3 for comparison of bone marrow edema quantification between wild-type and Tyro3/Axl/Mertk triple knock-out mice. These data are the same data as in Fig 3 for the wild-type mice, but presented in a different manner, to show the effect of aging on bone marrow edema.

https://doi.org/10.1371/journal.pone.0205902.s001

(TIF)

Acknowledgments

We thank Birgitte Walgreen for helping with tissue processing for histological analysis and immunohistochemical staining, Paqui González Traves for isolation of the joints and interesting exchanges of thoughts and ideas, Greg Lemke for kindly gifting the joints of all mice, and members of the Experimental Rheumatology department for useful discussions.

Citation: Waterborg CEJ, Koenders MI, van Lent PLEM, van der Kraan PM, van de Loo FAJ (2018) Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis. PLoS ONE 13(10): e0205902. https://doi.org/10.1371/journal.pone.0205902

References

1. You S, Koh JH, Leng L, Kim WU, Bucala R. The Tumor-Like Phenotype of Rheumatoid Synovium: Molecular Profiling and Prospects for Precision Medicine. Arthritis Rheumatol. 2017. pmid:29287304.

2. Angelotti F, Parma A, Cafaro G, Capecchi R, Alunno A, Puxeddu I. One year in review 2017: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(3):368–78. pmid:28631608.

3. Wu J, Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Gottsater A, et al. Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis research & therapy. 2011;13(2):R62. pmid:21496228; PubMed Central PMCID: PMCPMC3132057.

4. Kurowska-Stolarska M, Alivernini S, Melchor EG, Elmesmari A, Tolusso B, Tange C, et al. MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis. Nature communications. 2017;8:15877. pmid:28639625; PubMed Central PMCID: PMCPMC5489689.

5. van den Brand BT, Abdollahi-Roodsaz S, Vermeij EA, Bennink MB, Arntz OJ, Rothlin CV, et al. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis. Arthritis and rheumatism. 2013;65(3):671–80. Epub 2012/12/04. pmid:23203851; PubMed Central PMCID: PMC3582862.

6. Bassyouni IH, El-Wakd MM, Azab NA, Bassyouni RH. Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis. Int J Rheum Dis. 2014. pmid:24702788.

7. Ruiz-Heiland G, Zhao Y, Derer A, Braun T, Engelke K, Neumann E, et al. Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis. Annals of the rheumatic diseases. 2014;73(4):771–9. pmid:23632195.

8. Xu L, Hu F, Zhu H, Liu X, Shi L, Li Y, et al. Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction. Clin Exp Immunol. 2018;192(1):95–103. pmid:29148078.

9. O'Donnell K, Harkes IC, Dougherty L, Wicks IP. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. The American journal of pathology. 1999;154(4):1171–80. pmid:10233855; PubMed Central PMCID: PMCPMC1866575.

10. Waterborg CEJ, Beermann S, Broeren MGA, Bennink MB, Koenders MI, van Lent PLEM, et al. Protective role of the Mer Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models. Frontiers in Immunology. 2018;9. doi: ARTN 742 PubMed PMID: WOS:000429969000001. pmid:29706963

11. Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. TAM receptor signaling in immune homeostasis. Annual review of immunology. 2015;33:355–91. pmid:25594431; PubMed Central PMCID: PMC4491918.

12. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001;293(5528):306–11. Epub 2001/07/14. pmid:11452127.

13. Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F, et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 1999;398(6729):723–8. pmid:10227296.

14. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest. 2008;118(1):205–16. Epub 2007/12/07. pmid:18060042; PubMed Central PMCID: PMC2104479.

15. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Annals of the rheumatic diseases. 1998;57(6):350–6. pmid:9771209; PubMed Central PMCID: PMCPMC1752612.

16. Ostendorf B, Scherer A, Modder U, Schneider M. Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis and rheumatism. 2004;50(7):2094–102. pmid:15248206.

17. Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Annals of the rheumatic diseases. 2008;67(6):794–800. pmid:17981915.

18. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis and rheumatism. 2003;48(7):1814–27. pmid:12847674.

19. Boyesen P, Haavardsholm EA, van der Heijde D, Ostergaard M, Hammer HB, Sesseng S, et al. Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients. Annals of the rheumatic diseases. 2011;70(1):176–9. pmid:21068093.

20. Hetland ML, Ejbjerg B, Horslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Annals of the rheumatic diseases. 2009;68(3):384–90. pmid:18388160.

21. Hetland ML, Stengaard-Pedersen K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis—MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Annals of the rheumatic diseases. 2010;69(10):1789–95. pmid:20444751.

22. Duer-Jensen A, Horslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis and rheumatism. 2011;63(8):2192–202. pmid:21484772.

23. Kuca-Warnawin E, Burakowski T, Kurowska W, Prochorec-Sobieszek M, Radzikowska A, Chorazy-Massalska M, et al. Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15? Annals of the rheumatic diseases. 2011;70(1):227–33. pmid:20980284.

24. Jimenez-Boj E, Redlich K, Turk B, Hanslik-Schnabel B, Wanivenhaus A, Chott A, et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. Journal of immunology. 2005;175(4):2579–88. pmid:16081832.

25. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis and rheumatism. 2007;56(4):1118–24. pmid:17393390.

26. McQueen FM, Gao A, Ostergaard M, King A, Shalley G, Robinson E, et al. High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Annals of the rheumatic diseases. 2007;66(12):1581–7. pmid:17491098; PubMed Central PMCID: PMCPMC2095325.

27. Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, et al. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Annals of the rheumatic diseases. 2009;68(2):279–82. pmid:18765428.

28. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis and rheumatism. 2005;52(11):3448–59. pmid:16258900.

29. Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, et al. Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis and rheumatism. 2008;58(7):2019–29. pmid:18576355; PubMed Central PMCID: PMCPMC2572869.

30. Ey E, Yang M, Katz AM, Woldeyohannes L, Silverman JL, Leblond CS, et al. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes Brain Behav. 2012;11(8):928–41. pmid:22989184; PubMed Central PMCID: PMCPMC4904774.

31. Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS microbiology reviews. 2016;40(1):117–32. pmid:26323480; PubMed Central PMCID: PMC4703068.

32. Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. 2014;26(1):101–7. pmid:24247114; PubMed Central PMCID: PMCPMC4011633.

33. Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol. 2012;5(2):112–20. pmid:22274780.

34. Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Teles RP, Sampson K, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med. 2016;8(369):369ra176. pmid:27974664; PubMed Central PMCID: PMCPMC5384717.

35. Nassar M, Tabib Y, Capucha T, Mizraji G, Nir T, Pevsner-Fischer M, et al. GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa. Proceedings of the National Academy of Sciences of the United States of America. 2017;114(3):E337–E46. pmid:28049839; PubMed Central PMCID: PMCPMC5255577.